维普中文期刊产品整合服务
27篇 您的检索式:作者名="Palena"
    题名 作者 年代 出处 被引量
1Prolonged high-pressure balloon angioplasty of femoropopliteal lesions:Impact on stent implantation rate and mid-term outcome显示文摘ObjectivesTo 在 stent 培植率和回顾地注册的 femoropopliteal lesions.MethodsWe 的延长高压力 angioplasty 的中间的结果上估计影响从 2011 年 1 月的 620 个连续病人到 2011 年 12 月(75.6 ±12.3 年, 355 男性, 76.5% 在卢班 5-6 ) ,为批评手足局部缺血参考了并且提交了到 femoropopliteal 损害的延长高压的 angioplasty。延长高压的 angioplasty 的定义为至少 120 s 包括膨胀到至少 18 atm。程序的数据,和临床、仪器的后续被分析估计比较喜欢的培植率和中间的 outcomes.ResultsThe 接近的 stent 是 ipsilateral 在 433/620 病人(69.7%) 和在 164/620 (26.4%) 的 contralateral 转线路的大腿骨的 antegrade 并且腿弯部后退 +在 23/620 (3.7%)的大腿骨的 antegrade 。技术在 193/620 病人(31.2%) 在 427/620 病人(68.8%) 和 endoluminal angioplasty 包括了 subintimal angioplasty。延长高压力汽球 angioplasty 过程在 86.2% 是成功的(次要的 intra 程序的复杂并发症率 15.7 %) , stent 培植在 74 个病人(11.9%) 被执行,与脚关节臂的索引的重要改进(0.29 ±0.6 对 0.88 ±0.3, P <00.1 ) 并且卢班(5.3 ±0.8 对 0.7 ±1.9, P <0.01 ) , 86.7% 的主要明显率, Doppler 超声和在 18.1 ± 的吝啬的后续的 14.8% 的目标损害 revascularization 上的 18.6 % 的狭窄;6.4 个月(范围 1-24 月) 。第二等的明显率高是 87.7%.ConclusionsProlonged femoropopliteal 损害的压力 angioplasty 看起来安全、有效允许可接受的明显和狭窄在期中考试上评价。Gianluca Rigatelli Mariano Palena Paolo Cardaioli Fabio dell'Avvocata Massimo Giordan Dobrin Vassilev Marco Manzi 2014Journal of Geriatric Cardiology2014,11,2:2
2A human cytotoxic T-lymphocyte epitope and its agonist epitope from the nonvariable number of tandem repeat sequence of MUC-1显示文摘Tsang KY Palena C Gulley J 0,,:1
3Two E2F-binding sites independently control growth-regulated and cell-cycle regulated transcription of the Htfg-a/RanBPl gene显示文摘Di Fiore B Guarguaglini G Palena A 1999J Biol Chem1999,274,10:1
4Vaccines against human carcinomas: strategies to improve antitumor immune responses显示文摘Palena C Schlom J 2010J Biomed Biotechnol2010,2010,38:1
5Sublethal irradia- tion of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxie T lymphoeytes 显示文摘Garnett CT Palena C Chakraborty M 2004Cancer Res2004,64,21:1
6Tips and tricks for a correct “endo approach”显示文摘Ferraresi R Palena LM Mauri G 2013J Cardiovasc Surg (Torino)2013,54,:1
7Clinical effects of a standardized soy extract in postmenopausal women:a pilot study显示文摘Scambia G Mango D Signorile PG Anselmi Angeli RA Palena C Gallo D Bombardelli E Morazzoni P Riva A Mancuso S 2000Menopause2000,7,2:1
8An immunotherapeutic intervention against tumor progression:Targeting a driver of the epithelial-to-mesenchymal transition显示文摘Palena C Fernando RI Hamilton DH 2014Oncoimmunology2014,3,27:1
9Vascular imaging of the foot: the first step toward endovascular recanalization显示文摘Manzi M Cester G Palena LM 2011Radiographics2011,31,6:1
10The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells显示文摘Fernando Romaine I Litzinger Mary Trono Paola Hamilton Duane H Schlom Jeffrey Palena Claudia 2010Journal of Clinical Investigation2010,,2:1
11Chemotherapy‐induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death显示文摘James W. Hodge Charlie T. Garnett Benedetto Farsaci Claudia Palena Kwong‐Yok Tsang Soldano Ferrone Sofia R. Gameiro 2013Int J Cancer2013,,3:1
12Influence of IL-8on the epithelial-mesenchymal transition and the tumor microenvironment显示文摘Palena C Hamilton DH Fernando RI 2012Future Oncol2012,8,6:1
13Paclitaxel- coated balloon angioplasty for lower extremity revascularization : a new way to fight in - stent rest- enosis显示文摘Manzi M Cester G Palena LM 2010J Cardiovasc Surg(Torino)2010,51,4:1
14Homeoboxes in plant development显示文摘 Gago G M Palena C M Gonzalez D H 1998Biochim Biophys Acta1998,1442,:1
15Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvimnment显示文摘Palena C Hamilton DH Feruando RI 0,,06:1
16Chapter Two - Therapeutic Cancer Vaccines 显示文摘Schlom J Hodge J W Palena C 2014Advances in Cancer Research2014,,:1
17Positively charged residues at the N-terminal arm of the homeodomain are required for efficient DNA binding by homeodomain-leucine zipper proteins 1 1 Edited by M. Yaniv显示文摘Claudia M Palena Adriana E Tron Carlos W Bertoncini Daniel H Gonzalez Raquel L Chan 2001Journal of Molecular Biology2001,,1:1
18The human T box mesodermal transcription factor Brachyury is a candidate target for T-cell mediated Cancer immunotherapy显示文摘Palena C Polev DE Tsang KY 2007Clin Cancer Res2007,13,8:1
19The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cellmediated cancer immunotherapy显示文摘Palena C Polev DE Tsang KY 2007Clin Cancer Res2007,13,8:1
20Paclitaxelcoated balloon angioplasty for lower extremity revascularization:a new way to fight instent restenosis显示文摘Manzi M Cester G Palena LM 2010J Cardiovasc Surg (Torino)2010,51,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费